Rayence Co Ltd (228850)

Currency in KRW
6,530
+10(+0.15%)
Delayed Data·
228850 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 13 days
Fair Value
Day's Range
6,4506,530
52 wk Range
5,6208,500
Key Statistics
Bid/Ask
6,510.00 / 6,530.00
Prev. Close
6,520
Open
6,530
Day's Range
6,450-6,530
52 wk Range
5,620-8,500
Volume
1.17K
Average Volume (3m)
16.3K
1-Year Change
-16.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
228850 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9,250
Upside
+41.65%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Rayence Co Ltd Company Profile

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides radiography imaging software products, including Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS; medical information systems for veterinary hospitals; and engages in veterinary medical device and drug wholesale and retail business, as well as research and development of process facilities and deposition materials. The company was founded in 2011 and is headquartered in Hwaseong-si, South Korea.

Compare 228850 to Peers and Sector

Metrics to compare
228850
Peers
Sector
Relationship
P/E Ratio
27.8x10.7x−0.5x
PEG Ratio
−0.34−0.230.00
Price/Book
0.4x1.1x2.6x
Price / LTM Sales
0.9x1.5x3.3x
Upside (Analyst Target)
41.9%35.7%42.8%
Fair Value Upside
Unlock27.0%6.5%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9,250
(+41.65% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 234.56%
Dividend Yield
1.53%
Industry Median 1.05%
Annualised payout
100.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
1,085.00 / 1,085.00
Revenue / Forecast
27.20B / 37.80B
EPS Revisions
Last 90 days

228850 Income Statement

FAQ

What Stock Exchange Does Rayence Trade On?

Rayence is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Rayence?

The stock symbol for Rayence is "228850."

What Is the Rayence Market Cap?

As of today, Rayence market cap is 102.60B.

What Is Rayence's Earnings Per Share (TTM)?

The Rayence EPS (TTM) is 234.56.

When Is the Next Rayence Earnings Date?

Rayence will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 228850 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Rayence Stock Split?

Rayence has split 0 times.

How Many Employees Does Rayence Have?

Rayence has 228 employees.

What is the current trading status of Rayence (228850)?

As of 06 Aug 2025, Rayence (228850) is trading at a price of 6,530.00, with a previous close of 6,520.00. The stock has fluctuated within a day range of 6,450.00 to 6,530.00, while its 52-week range spans from 5,620.00 to 8,500.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.